[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
JAMA Guide to Statistics and Methods
June 16, 2015

Noninferiority TrialsIs a New Treatment Almost as Effective as Another?

Author Affiliations
  • 1Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, California
  • 2David Geffen School of Medicine at UCLA, Torrance, California
  • 3Los Angeles Biomedical Research Institute, Los Angeles, California
  • 4Berry Consultants, LLC
JAMA. 2015;313(23):2371-2372. doi:10.1001/jama.2015.6645

Sometimes the goal of comparing a new treatment with a standard treatment is not to find an approach that is more effective but to find a therapy that has other advantages, such as lower cost, fewer adverse effects, or greater convenience with at least similar efficacy to the standard treatment. With other advantages, a treatment that is almost as effective as a standard treatment might be preferred in practice or for some patients. The purpose of a noninferiority trial is to rigorously evaluate a new treatment against an accepted and effective treatment with the goal of demonstrating that it is at least almost as good (ie, not inferior).

First Page Preview View Large
First page PDF preview
First page PDF preview